Orum Therapeutics, Inc. (KOSDAQ:475830)

South Korea · Delayed Price · Currency is KRW

86,300

+8,700 (11.21%)

Apr 10, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biotechnology	135.42B	75.92M
Biotechnology Growth	178270.49%	-
Total	135.42B	75.92M
Total Growth	178270.49%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Korea	-	75.92M
United States	135.42B	-
Total	135.42B	75.92M
Total Growth	178270.49%	-

Source: S&P Global Market Intelligence.